Neurotherapeutics

SJR Rank #1,047H-index: 152SJR: 2.384Best quartile: Q1Open AccessAPC: US$3,900Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Neurology (clinical)Q1
  • PharmacologyQ1
  • Pharmacology (medical)Q1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Genetic Neurodegenerative DiseasesNeurological disorders and treatmentsNeuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsMultiple Sclerosis Research StudiesMitochondrial Function and PathologyTraumatic Brain Injury and Neurovascular DisturbancesEpilepsy research and treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025065130195260

Detailed Information

ISSN

1933-7213, 1878-7479

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

7.11

References per Document

78.82

Coverage

2007-2026

Scope

Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

Metrics from SCImago Journal Rank 2025. View on SCImago